Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis

Medical Science Monitor

Volumn 15, Issue 11, 2009, Pages

  Zezos, Petros ^a   Papaioannou, Georgia ^b   Nikolaidis, Nikolaos ^a   Patsiaoura, Kalliopi ^c   Vassiliadis, Themistoclis ^a   Mpoumponaris, Alexandros ^a   Giouleme, Olga ^a   Evgenidis, Nikolaos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

Coagulation; D dimers; Fibrinolysis; Prothrombin fragments 1 and 2 (F1+2); Thrombin antithrombin complex (TAT); Ulcerative colitis (UC)

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOLYSIS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; THROMBIN TIME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; DEMOGRAPHY; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STEROIDS; THROMBIN; YOUNG ADULT;

EID: 71649110713     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kucharzik T, Maaser C, Lugering A et al: Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis, 2006; 12: 1068-1083 (Pubitemid 44665477)
2. Hamilton M, Dick R, Crawford L: Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet, 1995; 345: 688-690
3. Wakefield AJ, Sawyerr AM, Dhillon AP et al: Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-1062 (Pubitemid 19264073)
4. Juhlin L, Krause U, Shelley WB: Endotoxin-induced microclots in ulcerative colitis and Crohn's disease. Scand J Gastroenterol, 1980; 15: 311-314 (Pubitemid 10124188)
5. Dhillon AP, Anthony A, Sim R et al: Mucosal capillary thrombi in rectal biopsies. Histopathology, 1992;21: 127-133
6. Lake AM, Stauffer JQ, Stuart MJ: Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis, 1978; 23: 897-902 (Pubitemid 9039622)
7. Hudson M, Chitolie A, Hutton RA et al: Thrombotic vascular risk factors in inflammatory bowel disease. Gut, 1996; 38: 733-737 (Pubitemid 26167482)
8. Chiarantini E, Valanzano R, Liotta AA et al: Hemostatic abnormalities in inflammatory bowel disease. Thromb Res, 1996;82: 137-146 (Pubitemid 26164662)
9. Talbot RW, Heppell J, Dozois RR, Beart RW Jr: Vascular complications of inflammatory bowel disease. Mayo Clin Proc, 1986; 61: 140-145 (Pubitemid 16127025)
10. Jackson LM, O'Gorman PJ, O'Connell J et al: Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM, 1997; 90: 183-188
11. Bernstein CN, Blanchard JF, Houston DS, Wajda A: The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost, 2001; 85: 430-434 (Pubitemid 32233013)
12. van Bodegraven AA: Hemostasis in inflammatory bowel diseases: clinical relevance. Scand J Gastroenterology, 2003; 38(Suppl.239): 51-62 (Pubitemid 38112916)
13. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology, 1995; 108: 1011-1015
14. Gaffney PR, Doyle CT, Gaffney A et al: Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastronterol, 1995; 90: 220-223
15. Torkvist L, Thorlacius H, Sjoqvist U et al: Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther, 1999; 13: 1323-1328 (Pubitemid 29462307)
16. Bevilacqua MP, Gimbrone MA Jr: Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost, 1987; 13: 425-433
17. Souto JC, Martinez E, Roca M et al: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci, 1995; 40: 1883-1889
18. Levi M, ten Cate H, van der Poll T: Endothelium: interface between coagulation and inflammation. Crit Care Med, 2002; 30: S220-24
19. Lee LC, Spittell JA Jr, Sauer WG et al: Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology, 1968; 54: 76-85
20. Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology, 1975; 68: 245-251
21. de Jong E, Porte RJ, Knot EA et al: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut, 1989; 30: 188-194
22. Conlan MG, Haire WD, Burnett DA: Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci, 1989; 34: 1089-1093 (Pubitemid 19188892)
23. Vecchi M, Cattaneo M, de Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res, 1991; 21: 165-170
24. Hudson M, Hutton RA, Wakefield AJ et al: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis, 1992; 3: 773-778 (Pubitemid 23026822)
25. Collins CE, Cahill MR, Newland AC, Rampton DS: Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology, 1994; 106: 840-845 (Pubitemid 24109268)
26. Kjeldsen J, Lassen JF, Brandslund I et al: Markers of coagulation and fi- brinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol, 1998; 33: 637-643 (Pubitemid 28300246)
27. Hayat M, Ariens RAS, Moayyedi P et al: Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol, 2002; 14: 249-256 (Pubitemid 34259273)
28. van Bodegraven AA, Schoorl M, Baak JPA et al: Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol, 2001; 96: 487-493
29. van Bodegraven AA, Schoorl M, Linskens RK et al: Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol, 2002; 14: 413-418 (Pubitemid 34439042)
30. Vrij AA, Rijken J, van Werch JWJ, Stockbrugger RW: Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis. Pathophysiol Haemost Thromb, 2003; 33: 75-83 (Pubitemid 37451780)
31. Walmsley RS, Ayres RCS, Pounder RE, Allan RN: A simple clinical colitis activity index. Gut, 1998; 43: 29-32
32. Vrij AA, Jansen JM, Schoon EJ et al: Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol Suppl, 2001; 234: 41-47
33. Stadnicki A, Kloczko J, Nowak A et al: Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis. Am J Gastroenterol, 1991; 86: 690-693
34. van Bodegranen AA, Tuynman ARE, Schoorl M et al: Fibrinolytic split products, fibrinolysis, and Factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol, 1995; 30: 580-585
35. Webberley MJ, Hart MT, Melikian V: Thromboembolism in inflammatory bowel disease: role of platelets. Gut, 1993; 34: 247-251 (Pubitemid 23049121)
36. Collins CE, Rampton DS: Review article: platelets in inflammatory bowel disease - pathogenetic role and therapeutic implications. Aliment Pharmacol Ther, 1997; 11: 237-247 (Pubitemid 27183501)
37. Stevens TJR, James JP, Simmonds NJ et al: Circulating von Willebrand factor in inflammatory bowel disease. Gut, 1992; 33: 502-506
38. Zezos P, Papaioannou G, Nikolaidis N et al: Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis re- flect endothelial perturbation due to systemic inflammation. World J Gastroenterol, 2005; 1: 7639-7645 (Pubitemid 43168429)
39. Kume K, Yamasaki M, Tashiro M et al: Activations of coagulation and fi- brinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med, 2007; 46: 1323-1329
40. Aadland E, Odegaard OR, Roseth A, Try K: Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol, 1994; 29: 333-335 (Pubitemid 24128380)
41. Jorens PG, Hermans CR, Haber I et al: Acquired protein C and S defi- ciency, inflammatory bowel disease, and cerebral arterial thrombosis. Blut, 1990; 61: 307-310
42. Zezos P, Papaioannou G, Nikolaidis N et al: Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis. Hepatogastroenterology, 2007; 54: 1417-1421 (Pubitemid 47203439)
43. Miehsler W, Reinisch W, Valic E et al: Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut, 2004; 53: 542-548
44. Smith CJ, Haire WD, Kaufman SS, Mack DR: Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol, 1996; 6: 1221-1225
45. Weber P, Husemann S, Vielhaber H et al: Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 1999; 28: 418-422 (Pubitemid 30349252)
46. Stadnicki A, Gonciarz M, Niewiarowski TJ et al: Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis. Dig Dis Sci, 1997; 42: 2356-2366 (Pubitemid 28005000)
47. Podolsky DK: Inflammatory bowel disease. N Engl J Med, 2002; 347: 417-429
48. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999; 340: 448-454 (Pubitemid 29084777)
49. Grip O, Svensson PJ, Lindgren S: Inflammatory bowel disease promotes venous thromboses earlier in life. Scand J Gastroenterol, 2000; 35: 619-623 (Pubitemid 30441713)
50. Bernstein CN, Wajda A, Blanchard JF: The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol, 2008; 6: 41-45 (Pubitemid 50008413)
51. Hatoum OA, Binion DG: The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis, 2005; 11: 304-313 (Pubitemid 40439685)
52. Papa A, Danese S, Urgesi R et al: Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci, 2006; 10: 7-11 (Pubitemid 43299603)
53. Papa A, Santoliquido A, Danese S et al: Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther, 2005; 22: 839-846 (Pubitemid 41564364)